The evaluation of the effectiveness of treatment was carried out by s.c. injecting the syngeneic murine melanoma cell line B16F10 in the right flank of female C57BL/6NCrl mice that were treated with ascorbate, anti-PD1 immunotherapy, or the combination of both in the following. The gene discussed is PDCD1; the disease is melanoma.